These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 12954229

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
    Amtoft HW, Sørensen AB, Bareil C, Schmidt J, Luz A, Pedersen FS.
    J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
    [Abstract] [Full Text] [Related]

  • 3. Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.
    Nielsen AA, Sørensen AB, Schmidt J, Pedersen FS.
    J Virol; 2005 Jan; 79(1):67-78. PubMed ID: 15596802
    [Abstract] [Full Text] [Related]

  • 4. Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus.
    Martiney MJ, Rulli K, Beaty R, Levy LS, Lenz J.
    J Virol; 1999 Sep; 73(9):7599-606. PubMed ID: 10438850
    [Abstract] [Full Text] [Related]

  • 5. Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer.
    Ethelberg S, Tzschaschel BD, Luz A, Diaz-Cano SJ, Pedersen FS, Schmidt J.
    J Virol; 1999 Dec; 73(12):10406-15. PubMed ID: 10559359
    [Abstract] [Full Text] [Related]

  • 6. Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses.
    Lund AH, Schmidt J, Luz A, Sørensen AB, Duch M, Pedersen FS.
    J Virol; 1999 Jul; 73(7):6117-22. PubMed ID: 10364369
    [Abstract] [Full Text] [Related]

  • 7. Recombinant Origins of Pathogenic and Nonpathogenic Mouse Gammaretroviruses with Polytropic Host Range.
    Bamunusinghe D, Liu Q, Plishka R, Dolan MA, Skorski M, Oler AJ, Yedavalli VRK, Buckler-White A, Hartley JW, Kozak CA.
    J Virol; 2017 Nov 01; 91(21):. PubMed ID: 28794032
    [Abstract] [Full Text] [Related]

  • 8. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
    Sørensen KD, Quintanilla-Martinez L, Kunder S, Schmidt J, Pedersen FS.
    J Virol; 2004 Dec 01; 78(23):13216-31. PubMed ID: 15542674
    [Abstract] [Full Text] [Related]

  • 9. Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3.
    Nieves A, Levy LS, Lenz J.
    J Virol; 1997 Feb 01; 71(2):1213-9. PubMed ID: 8995644
    [Abstract] [Full Text] [Related]

  • 10. Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.
    Lawrenz-Smith SC, Massey AC, Innes DJ, Thomas CY.
    J Virol; 1994 Aug 01; 68(8):5174-83. PubMed ID: 8035516
    [Abstract] [Full Text] [Related]

  • 11. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
    Johnson C, Lobelle-Rich PA, Puetter A, Levy LS.
    J Virol; 2005 Jan 01; 79(1):57-66. PubMed ID: 15596801
    [Abstract] [Full Text] [Related]

  • 12. Unique three-repeat sequences containing FVa, LVb/C4, and CORE motifs in LTR-U3 of Friend murine leukemia virus clone A8 accelerate the induction of thymoma in rat.
    Takase-Yoden S, Watanabe R.
    Virology; 2004 Aug 15; 326(1):29-40. PubMed ID: 15262492
    [Abstract] [Full Text] [Related]

  • 13. Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.
    Ethelberg S, Hallberg B, Lovmand J, Schmidt J, Luz A, Grundström T, Pedersen FS.
    J Virol; 1997 Feb 15; 71(2):1196-206. PubMed ID: 8995642
    [Abstract] [Full Text] [Related]

  • 14. Duplication of U3 sequences in the long terminal repeat of mink cell focus-inducing viruses generates redundancies of transcription factor binding sites important for the induction of thymomas.
    DiFronzo NL, Frieder M, Loiler SA, Pham QN, Holland CA.
    J Virol; 2003 Mar 15; 77(5):3326-33. PubMed ID: 12584358
    [Abstract] [Full Text] [Related]

  • 15. B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer.
    Lovmand J, Sorensen AB, Schmidt J, Ostergaard M, Luz A, Pedersen FS.
    J Virol; 1998 Jul 15; 72(7):5745-56. PubMed ID: 9621033
    [Abstract] [Full Text] [Related]

  • 16. Role of the LTR region between the enhancer and promoter in mink cell focus-forming murine leukemia virus pathogenesis.
    Yoshimura FK, Wang T.
    Virology; 2001 Apr 25; 283(1):121-31. PubMed ID: 11312668
    [Abstract] [Full Text] [Related]

  • 17. The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity.
    Pantginis J, Beaty RM, Levy LS, Lenz J.
    J Virol; 1997 Dec 25; 71(12):9786-91. PubMed ID: 9371646
    [Abstract] [Full Text] [Related]

  • 18. An SL3-3 murine leukemia virus enhancer variant more pathogenic than the wild type obtained by assisted molecular evolution in vivo.
    Ethelberg S, Sørensen AB, Schmidt J, Luz A, Pedersen FS.
    J Virol; 1997 Dec 25; 71(12):9796-9. PubMed ID: 9371648
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.
    Nishigaki K, Hanson C, Thompson D, Yugawa T, Hisasue M, Tsujimoto H, Ruscetti S.
    J Virol; 2002 Feb 25; 76(3):1527-32. PubMed ID: 11773427
    [Abstract] [Full Text] [Related]

  • 20. Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
    Ethelberg S, Lovmand J, Schmidt J, Luz A, Pedersen FS.
    J Virol; 1997 Oct 25; 71(10):7273-80. PubMed ID: 9311802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.